Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Hanwha Aerospace (012450) to Hold Investor Relations (IR) for Q1 2025 Earnings

Posted on April 14, 2025July 20, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Aerospace (012450) to Hold Investor Relations (IR) for Q1 2025 Earnings

Fact Source: Financial Supervisory Service DART / 2025-04-14

Disclosure Type: Holding of Investor Relations (IR) (Information Disclosure)

💡 3-Second Summary

Hanwha Aerospace will hold an Investor Relations (IR) event from May 7 to May 9, 2025, targeting domestic institutional investors to present its business performance and outlook for the first quarter of 2025.

📊 1. [Summary of Core Disclosure Content and Major Figures]

  • Timeline and Location: May 7, 2025 – May 9, 2025, at major domestic investment institutions (Yeouido, Seoul, etc.)
  • Target Audience: Domestic institutional investors
  • Purpose: To enhance investor understanding by explaining Q1 2025 management performance.
  • Method: 1-on-1 meetings and group meetings (conference calls).
  • Sponsoring Institution: Daishin Securities
  • Key Content: Q1 2025 business performance, future outlook, and Q&A session.
  • IR Material Availability: Scheduled to be posted on the company’s official website on April 30, 2025.

📈 2. [Expert Perspective: What This Disclosure Means for Investors]

  • IR Meeting Formats: This event is organized for domestic institutional investors and utilizes a dual structure, combining physical 1-on-1 sessions with remote group conference calls.
  • Material Scheduling: According to the text, preceding the investor meetings scheduled for May 7, the underlying IR presentation materials are designated to be disclosed beforehand on the corporate website on April 30, 2025.
  • Potential Schedule Changes: As noted in the disclosure, the detailed operational timeline specified from May 7 to May 9 retains a possibility of alteration depending on future arrangements.

📝 Editor’s Comment (by K-STOCK Editor)

This announcement outlines the operational timeline and data publication dates for Hanwha Aerospace’s Q1 2025 business results and forward-looking outlook. The designated window incorporates a structured session for presenting earnings alongside a dedicated Q&A track.

The primary objective variable for investors to track next is April 30, 2025. Since the disclosure notes that the IR materials will be posted on the official website prior to the meetings, reviewing the exact financial numbers and specific outlook metrics published on that date is the initial step.

Subsequently, investors should verify whether the scheduled sessions proceed from May 7 to May 9 without timeline adjustments. Because this filing is strictly a preliminary notification of the event itself, the finalized increases or decreases in Q1 performance metrics must be checked through the official materials released on April 30.

📢 Disclaimer & Source Information

Source: This content has been structured and newly generated based on official data submitted to the Financial Supervisory Service’s Electronic Disclosure System (DART).

Investment Risk Notice: This information is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial liabilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Defense

Post navigation

Previous Post: [Disclosure] Jeju Semiconductor (080220) Triggered as ‘Short Selling Overheated Stock’… Short Sales Banned for April 15
Next Post: [Disclosure] Hanwha Aerospace (012450) to Hold Investor Relations (IR) for Q1 2025 Earnings

Related Posts

[Disclosure] Celltrion Obtains European Phase 3 Clinical Trial Approval (Part1&2) for Zymfentra (CT-P13 SC) in Rheumatoid Arthritis (068270) Disclosures
[Disclosure] Celltrion (068270) Submits Phase 3 Clinical Trial Application (IND) for ‘Keytruda Biosimilar (CT-P51)’ to South Korean MFDS Disclosures
[Disclosure] Celltrion (068270) Amends AGM Convocation Notice; Updates Inside Director Nominee to Shin Min-chul and Expands Treasury Share Cancellation Plan Disclosures
[Disclosure] Hanwha Ocean (042660) Formally Schedules Q3 2024 Earnings Release and Investor Relations (IR) Conference for October 29 Disclosures
[Disclosure] Alteogen (196170) to Hold IR Meetings in Hong Kong & Singapore for Global Institutional Investors to Share Mid-to-Long Term Growth Strategy and R&D Progress Disclosures
[Disclosure] Hanwha Aerospace (012450) Decides to Provide Debt Guarantee of Approx. KRW 1.8T for Newly Established Subsidiary ‘Hanwha WB Advanced System’ Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme